Skip to content

ONCY

Oncolytics Biotech, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$0.77
+0.00%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 11, 2026
EPS estimate
-$0.07
Revenue estimate

Latest reported

Last report date
Aug 12, 2026
EPS actual
-$0.08
EPS estimate
-$0.05
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
7
EPS misses (12Q)
4
EPS in line (12Q)
1
Avg surprise (4Q)
-31.3%
Revenue beats (12Q)
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 12, 2026-$0.05-$0.08Miss -48.70%
May 14, 2026-$0.05-$0.08Miss -60.00%
Mar 30, 2026-$0.06-$0.08Miss -33.33%
Nov 12, 2025-$0.12-$0.10Beat 16.67%
Aug 8, 2025-$0.11-$0.05Beat 54.55%
May 14, 2025-$0.09-$0.06Beat 33.33%
Mar 7, 2025-$0.08-$0.07Beat 12.50%
Aug 1, 2024-$0.08-$0.07Beat 12.50%
May 9, 2024-$0.09-$0.07Beat 22.22%
Mar 7, 2024-$0.11-$0.04Beat 63.64%
Nov 3, 2023-$0.07-$0.10Miss -42.86%
Aug 14, 2023-$0.09-$0.09In line

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026